BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8874862)

  • 1. Effects of endothelial cells on activity of staphylokinase.
    Ueshima S; Okada K; Matsumoto H; Takaishi T; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 1996 Jul; 7(5):522-9. PubMed ID: 8874862
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of plasminogen activation by the plasmin-staphylokinase complex in plasma of alpha2-antiplasmin-deficient mice.
    Okada K; Ueshima S; Tanaka M; Fukao H; Matsuo O
    Blood Coagul Fibrinolysis; 2000 Oct; 11(7):645-55. PubMed ID: 11085285
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of fibrin and alpha2-antiplasmin on plasminogen activation by staphylokinase.
    Okada K; Ueshima S; Takaishi T; Yuasa H; Fukao H; Matsuo O
    Am J Hematol; 1996 Nov; 53(3):151-7. PubMed ID: 8895684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of fibrin-specific fibrinolysis by staphylokinase: participation of alpha 2-plasmin inhibitor.
    Sakai M; Watanuki M; Matsuo O
    Biochem Biophys Res Commun; 1989 Jul; 162(2):830-7. PubMed ID: 2527034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrin-specific fibrinolysis induced by recombinant staphylokinase.
    Shishido Y; Matsumoto T; Sakai M; Kaneda N; Sansawa H; Shimura K; Hashimoto S; Yokokura T
    Biol Pharm Bull; 1994 Aug; 17(8):1060-4. PubMed ID: 7820108
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of alpha 2-plasmin inhibitor on plasminogen activation by staphylokinase/plasminogen complex.
    Okada K; Nonaka T; Matsumoto H; Fukao H; Ueshima S; Matsuo O
    Thromb Res; 1994 Oct; 76(2):211-20. PubMed ID: 7863470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetic analysis of plasminogen activation by staphylokinase/plasminogen complex in the presence of fibrin.
    Okada K; Yuasa H; Hagiya Y; Fukao H; Ueshima S; Matsuo O
    Thromb Res; 1994 Oct; 76(2):181-91. PubMed ID: 7863467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of activation of mammalian plasma fibrinolytic systems with streptokinase and with recombinant staphylokinase.
    Collen D; Van Hoef B; Schlott B; Hartmann M; Gührs KH; Lijnen HR
    Eur J Biochem; 1993 Aug; 216(1):307-14. PubMed ID: 7689966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of staphylokinase on platelet aggregation.
    Suehiro A; Oura Y; Ueda M; Kakishita E
    Thromb Haemost; 1993 Nov; 70(5):834-7. PubMed ID: 7510426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation by alpha 2-antiplasmin and fibrin of the activation of plasminogen with recombinant staphylokinase in plasma.
    Silence K; Collen D; Lijnen HR
    Blood; 1993 Aug; 82(4):1175-83. PubMed ID: 7688990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of protease inhibitors in staphylokinase-induced fibrin-specific fibrinolysis.
    Shishido Y; Sakai M; Kaneda N; Sansawa H; Shimura K; Hashimoto S; Yokokura T
    Biol Pharm Bull; 1994 Dec; 17(12):1595-8. PubMed ID: 7735201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of staphylokinase concentration of plasminogen activation.
    Arai K; Mimuro J; Madoiwa S; Matsuda M; Sako T; Sakata Y
    Biochim Biophys Acta; 1995 Aug; 1245(1):69-75. PubMed ID: 7654768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of human plasminogen by staphylokinase. Direct evidence that preformed plasmin is necessary for activation to occur.
    Grella DK; Castellino FJ
    Blood; 1997 Mar; 89(5):1585-9. PubMed ID: 9057640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel recombinant thrombolytic and antithrombotic staphylokinase variants with an RGD motif at their N-termini.
    He J; Di J; Xu R; Zhao B
    Biotechnol Appl Biochem; 2008 May; 50(Pt 1):17-23. PubMed ID: 18039183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic properties of staphylokinase.
    Matsuo O; Okada K; Fukao H; Tomioka Y; Ueshima S; Watanuki M; Sakai M
    Blood; 1990 Sep; 76(5):925-9. PubMed ID: 2118398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new recombinant thrombolytic and antithrombotic agent with higher fibrin affinity--a staphylokinase variant. I. In vitro study.
    Szemraj J; Walkowiak B; Kawecka I; Janiszewska G; Buczko W; Bartkowiak J; Chabielska E
    J Thromb Haemost; 2005 Oct; 3(10):2156-65. PubMed ID: 16150047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced plasminogen activation by staphylokinase in the presence of streptokinase beta/betagamma domains: plasminogen kringles play a role.
    Dahiya M; Rajamohan G; Dikshit KL
    FEBS Lett; 2005 Mar; 579(7):1565-72. PubMed ID: 15757642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between staphylokinase, plasmin(ogen), and alpha 2-antiplasmin. Recycling of staphylokinase after neutralization of the plasmin-staphylokinase complex by alpha 2-antiplasmin.
    Silence K; Collen D; Lijnen HR
    J Biol Chem; 1993 May; 268(13):9811-6. PubMed ID: 7683664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic studies on the plasminogen activation by the staphylokinase-plasmin complex.
    Shibata H; Nagaoka M; Sakai M; Sawada H; Watanabe T; Yokokura T
    J Biochem; 1994 Apr; 115(4):738-42. PubMed ID: 8089091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fusion proteins with anticoagulant and fibrinolytic properties: functional studies and structural considerations.
    Icke C; Schlott B; Ohlenschläger O; Hartmann M; Gührs KH; Glusa E
    Mol Pharmacol; 2002 Aug; 62(2):203-9. PubMed ID: 12130670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.